In contrast, TFRC expression remained unchanged in the negative control FARAGE after PTPN2 knockout, highlighting the specificity of this regulatory mechanism in ALK+ ALCL (Figure S3A–C, Supporting Information). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.